
éå ± :ããçŽ ãšåäŸã®IQäœäžãé¢é£ã¥ããæ°ããªç ç©¶ããæ°Žéæ°ŽããçŽ å廿¢ãæ±ãã声ã«åã³ç«ãã€ãã
å èšäºã¯ãã¡ããã/Click here to read the original article.
åäŸã®IQãšããåç©æé²ã®é¢é£ã調ã¹ã74ã®ç«åŠç ç©¶ã®ã¡ã¿ã¢ããªã·ã¹ã«ãããšãåŠå©Šã幌å ãããå€ãã®ããåç©ã«æé²ãããã»ã©ãåäŸã®IQã®äœäžã倧ããããšãæããã«ãªã£ãããã®ç ç©¶ã¯ãæ¬æ¥JAMA Pediatricsèªã«çºè¡šããããã®ã§ãNIH National Toxicology Programã®ç§åŠè ã«ãã£ãŠè¡ãããã
åã©ãã®IQãšããåç©æé²ã®é¢é£ã調ã¹ã74ã®ç«åŠç ç©¶ã®ã¡ã¿ã¢ããªã·ã¹ã«ãããåŠå©Šã幌å ãããåç©ã«æé²ãããéãå€ãã»ã©ãåã©ãã®IQã®äœäžã倧ããããšãæããã«ãªã£ãã
æ¬æ¥JAMA Pediatricsèªã«çºè¡šããããã®ç ç©¶ã¯ãç±³åœåœç«è¡çç ç©¶æïŒNIHïŒã®åœå®¶æ¯æ§ããã°ã©ã ïŒNTPïŒã®ç§åŠè ã«ãã£ãŠè¡ãããã
ãã®ç¶¿å¯ãªçµ±èšçã¡ã¿ã¢ããªã·ã¹ã¯ãããåç©ã«é¢ããç ç©¶ãšããŠã¯é廿倧ãã€æãå³å¯ãªãã®ã§ããããã®ç ç©¶çµæã¯ããå šèº«çãªããåç©æé²ãåè©äŸ¡ãããå¿ èŠæ§ã匷調ããŠããã
ç ç©¶è ãã¯ãæ¢åã®ç ç©¶ãäžççã«åæãããã®è³ªãè©äŸ¡ããå¹Žéœ¢ãæ§å¥ãããåç©æ¿åºŠã䜿çšããèªç¥æ€æ»ã®çš®é¡ãããåç©æé²ã®æž¬å®æ¹æ³ãç ç©¶å Žæãªã©ã®å€æ°ãèæ ®ããã
ãã®çµæãããåç©æé²éãšåã©ãã®IQã¹ã³ã¢ã®éã«ææãªéçžé¢ãããããšã倿ãããã€ãŸããåŠå©Šã幌å ãæé²ããããåç©éãå¢ããã«ã€ããŠãIQã¯äœäžãããšããããšã§ããã
ã€ãŸããåŠå©Šã幌å ãããåç©ã«æé²ãããéãå¢ããã«ã€ããŠãIQã¯äœäžãããšããããšã§ããããŸãã質ã®é«ãç ç©¶ã§ã¯ãããåç©æ¿åºŠãé«ããŠãäœããŠãããã®åœ±é¿ã¯ææã§ãã£ãã
ããŒã¿ã¯ãé£²ææ°Žããã³å°¿äžã®ããåç©æ¿åºŠïŒäººã®ç·ããåç©æé²éãæšå®ããïŒã4ããªã°ã©ã /ãªããã«ïŒmg/LïŒæªæºã2mg/Læªæºã1.5mg/Læªæºã®ãµãã°ã«ãŒãã«åããããã
å°¿äžã®ããåç©ã1mg/Lå¢å ããããšã«ãåã©ãã®IQã¯1.63ãã€ã³ãäœäžããã
ç ç©¶è ãã¯ãæé²ã®ã³ã³ãã©ã¹ããåå®ããã®ãããå°é£ã§ãã£ããããããäœãã¬ãã«ã§ã¯çµæã¯ããäžç¢ºå®ã§ãã£ããšè¿°ã¹ãŠããã
ç±³åœå ¬è¡è¡çå±ã¯ã2015幎ã«0.7-1.2mg/Lã®æšå¥šå€ããåŒãäžãã0.7mg/Lã®ããåç©æ·»å ãæšå¥šããŠããã
ç±³åœã§ã¯ã人ã®ããåç©æåéã®çŽ40ïœ70ïŒ ãããçŽ æ·»å ãããé£²ææ°ŽããæåãããŠããã
ããããæ°Žäžã®ããåç©æ¿åºŠã ãã§ã¯ããã®äººã®ç·ããåç©æé²éãéå°è©äŸ¡ããŠããå¯èœæ§ãé«ãããšç ç©¶ã¯è¿°ã¹ãŠãããç·æé²éã¯ãæ°Žãã³ãŒããŒãçŽ è¶ã飲ãéãå å·¥é£åã®æ¶è²»éãä¹³å ãæ¯ä¹³ã§ã¯ãªãç²ãã«ã¯ã飲ããã©ãããæ¯ç£šãç²ãããŠã¹ãŠã©ãã·ã¥ã®ãããªããçŽ å ¥ã補åã䜿ããã©ãããªã©ãå人ã®è¡åã«ãã£ãŠç°ãªãã
JAMAã®ã¡ã¿ã¢ããªã·ã¹ã¯ãNTPã®ç§åŠè ã2015幎ã«éå§ããããåç©æé²ãšåäŸã®IQäœäžãšã®é¢é£ã«ã€ããŠã®èª¿æ»ã®äžéšã§ãããç§åŠè ãã¡ã¯ã8æã«ã¢ãã°ã©ããçºè¡šãã仿¥ã®ã¡ã¿ã¢ããªã·ã¹ãçºè¡šãããäž¡è ãšããçºéäžã®è³ã«å¯Ÿããããåç©ã®ç¥çµæ¯æ§äœçšã«é¢ããåºç¯ãªããŒã¿ãæäŸããŠããã
NTPã®çºè¡šã¯ãç±³åœæ¯ç§å»åž«äŒïŒADAïŒãå ¬è¡è¡çåœå±ãå«ãããçŽ ãããŒå£äœã«ããæ°å¹Žã«ãããå察éåã®åŸãåãããã®ã§ã圌ãã¯çºè¡šã劚害ããèè ãã¡ã«å§åããããŠç ç©¶çµæã匱ãããé ããããããããšããã
ãã®ç ç©¶ã¯ãNTPãè¡ã£ãä»ã®ãã¹ãŠã®ç ç©¶ãšæ¯èŒããŠãåäŸã®ãªãéã®æ»èªãåããããNTPã®å 責任è ã¯ãDefenderãçŽã«å¯Ÿããæ¿æ²»çäž»å°ã§ãã£ããšèªã£ãã
ãã®ç ç©¶çµæã¯ããããåç©ã«é¢ããå°æ¥ã®å æ¬çãªå ¬è¡è¡çãªã¹ã¯ã»ãããã£ããè©äŸ¡ã«åœ¹ç«ã€ãããããªãããšèè ãã¯çµè«ã¥ããã
æ°Žéæ°ŽãããªããŒã·ã§ã³ãããã倧éšå
JAMA Pediatricsèªã¯ãæ°Žéæ°ŽãããªããŒã·ã§ã³ãããã倧éšãã®äžã§ã¡ã¿åæãçºè¡šããã
å ¬è¡è¡çåœå±ãšæ¯ç§ãããŒã¯ãäœå幎ãã®éãæ°Žéæ°ŽãããªããŒã·ã§ã³ã¯çãäœå°ã®ãªãå ¬å ±ã®å©çã§ããã20äžçŽã®10å€§å ¬è¡è¡çææã®äžã€ã§ãããšäž»åŒµããŠããã圹人ãã¡ã¯ãã°ãã°ãããçŽ å¡åžã«çåãåããåžæ°ãäžæµã®ç§åŠè ãã¡ãé°è¬è«è ãšèŠãªããŠããã
ããããããåç©ã«é¢ããç§åŠççè§£ã¯é·å¹Žã«ããã£ãŠé²å±ããå ¬è¡è¡çæ©é¢ã70幎è¿ãåã«å°å瀟äŒã«ããåç©ã®æ°Žéæ°Žãžã®æ·»å ãæšå¥šãå§ãããšãã«ã¯ç¥ãããŠããªãã£ãããããã¯ç¡èŠãããŠããããåç©ã®æ¯æ§äœçšïŒåã©ãã®èªç¥çºéãå«ãïŒãæããã«ãªã£ãã
å®å šãªæ°Žéæ°ŽãããªããŒã·ã§ã³ã®ããã®çŸåšã®æšå¥šã¯ãæ¯ã®ããçŽ çã®ãªã¹ã¯ã®ã¿ãèæ ®ãããã®ã§ãããããã¯å°å æã®ããçŽ ãžã®éå°æé²ã«ãã£ãŠåŒãèµ·ããããæ¯ã®å€è²ã§ãããç±³åœäººå£ã®çŽ23ïŒ ã眹æ£ããŠããããããªããŒã·ã§ã³ãç¥çµèªç¥ã«åãŒãå¯èœæ§ã«åºã¥ãå§åãå¶éã¯ååšããªãã
ãããã2024幎ã ãã§ããNTPã®ã¢ãã°ã©ãããé£²ææ°Žäžã®ããåç©æŽé²ã¬ãã«ãé«ãã»ã©ãåã©ãã®IQãäœããªããšäžè²«ããŠé¢é£ããŠãããšçµè«ã¥ããŠããã®ã«å ããŠã5æã«JAMA Network Openã«çºè¡šãããç ç©¶ã§ã¯ãããµã³ãŒã«ã¹ã§ããçŽ æ·»å ãããé£²ææ°Žã«åŠåš äžã«æŽé²ããã女æ§ããçãŸããåã©ãã¯ãç¥çµè¡ååŠçåé¡ãæ±ããå¯èœæ§ãé«ãããšãããã£ãã
2024幎9æãé£éŠå€äºã¯ãNTPã®ç ç©¶ãå«ãç§åŠç蚌æ ã¯ãçŸåšã®ç±³åœã¬ãã«ã§ã®æ°Žéæ°ŽãããªããŒã·ã§ã³ãåäŸã®IQäœäžã®ãäžåçãªãªã¹ã¯ããããããããšã瀺ããŠãããšè£å®ããç°å¢ä¿è·åºïŒEPAïŒã«èŠå¶æªçœ®ããšãããåœããã
ãã®å€æ±ºã«ããã7幎以äžç¶ããç°å¢ä¿è·å±ã«å¯ŸããæŽå²çãªèšŽèšã¯çµçµããããã®èšŽèšã¯ãç°å¢ä¿è·å£äœãæ¶è²»è æè·å£äœããããŠãããªããŒã·ã§ã³å»æ¢ãæ±ããåã ã®èŠªåã«ãã£ãŠèµ·ããããã
2024幎9æã®å€æ±ºãã2é±éãçµããªããã¡ã«ãã³ã¯ã©ã³ã¯ææ°ã®ã¬ãã¥ãŒãçºè¡šããé£²ææ°Žãžã®ããçŽ æ·»å ã¯ãç¹ã«50幎åãšæ¯èŒããŠãæ¯ç§ç广ããããšããŠããããããã§ãããšçµè«ã¥ããã
ãã以æ¥ãã¢ã¡ãªã«äžã®å€ãã®åžãçºãæ°Žéæ°ŽãããªããŒã·ã§ã³å»æ¢ã決å®ããããããªãå·ã®å€ç§å»ç·é·ã¯ãç¹ã«åŠå©ŠãåäŸã«å¯Ÿããç¥çµç²Ÿç¥å»åŠçãªã¹ã¯ãæããåèªæ²»äœã«ããçŽ æ·»å ãäžæ¢ããããå§åããã
ããã«ãã»ãã©ã³ã次æå€§çµ±é ã®ä¿å¥çŠç¥çïŒHHSïŒé·å®åè£ã§ãããããŒãã»Fã»ã±ããã£ã»ãžã¥ãã¢ã¯ããã©ã³ã倧統é ã¯å°±ä»»åæ¥ã«æ°Žéæ°ŽãããªããŒã·ã§ã³å»æ¢ãæšé²ããã ãããšãœãŒã·ã£ã«ã¡ãã£ã¢ã§çºèšããã
ãã®ã±ããã£ã®çºèšããã£ããã«ãããçŽ å¡åžãæè·ããèšäºãäž»èŠçŽã§çžæ¬¡ãã ããããçŽ å¡åžã«é¢ããåŸæ¥ã®åžžèãèŠçŽãå¿ èŠãããããšãèªããã³ã¡ã³ãããã£ãã
HHSã«ã¯çŸç 管çäºé²ã»ã³ã¿ãŒïŒCDCïŒããããæ°Žéæ°ŽãããªããŒã·ã§ã³ã¬ãã«ã«é¢ããå§åãè¡ã£ãŠããã
2ã€ã®è«è©ïŒå°éå®¶ã®è°è«
ã¢ã€ãªã¯å€§åŠææã§ãããADAã®åœå®¶ããçŽ åè«®åå§å¡äŒã®ã¡ã³ããŒã§ããSteven M. Levyå士ã¯ãæ¬æ¥ã®JAMAã®ç ç©¶ã«å¯ŸããŠèŸèŸ£ãªåè«ãæžããèè ããéžæçã«ç ç©¶ãçã蟌ã¿ããè«æã®åŠ¥åœæ§ãšæçšæ§ã«å®è³ªçãªæžå¿µãæ±ããã ãæ¹æ³ã§åæãè¡ã£ãŠãããšéé£ããã
ã¬ããŒã¯ãæ»èªè ã«ããæ¹è©ã以åã®çµè«ã«å ãããã倿Žã«ã€ããŠèè ããè°è«ããŠããªãããšãæ¹å€ããããããã®æ¹è©ã®å€ãã¯ãè£å€äžã«ååãæ å ±å ¬éæ³ïŒFOIAïŒã®èŠæ±ãéããŠå ¥æããææžã§æããã«ãªã£ãå ¬çããã³èå°è£ã®å§åã«ãã£ãŠãã¬ãŽã£ãšåœŒãå§å¡ãåããADAå§å¡äŒã«ãã£ãŠäžéšæšé²ããããã®ã§ããã
ã¬ãŽã£ã¯4ããŒãžã«ãããåçæžã®äžã§ããžã£ã€ã³ã¹ã»Vã»ã¯ããŒã«å士ãã«ããã¡ã¿åæã9åãåŒçšããNTPã®èª¿æ»çµæãåŠå®ããéèŠãªèšŒæ ãšããããã®åæã§ã¯ãããåç©ãšäœããçŽ åã¬ãã«ã§ã®IQäœäžãšã®éã«é¢é£ã¯ãªããšããŠããã
ã¯ããŒã«ãšã¬ããŒã¯ADAè«®åå§å¡äŒã®ååã§ããããã®ç ç©¶ã¯ãã³ã«ã²ãŒã瀟ããè³éæäŸãåããŠããã¹ãŒã¶ã³ã»ãã£ãã·ã£ãŒïŒãªãŒãŠã§ã³ãºå士ãšã®å ±èã§ãããå ¬ææžè«æ±ã§å ¥æããé»åã¡ãŒã«ã«ããã°ããã®ç ç©¶ã¯èè ãã¡ã®çµè«ã«åããããŒã¿ãæå³çã«çç¥ããNTPã®å ±åæžãæå³çã«åŒ±äœåãããããšããã
ããçŽ è£å€ã®åååŽåŒè·å£«ã§ãããã€ã±ã«ã»ã³ãããã¯ãããã£ãã§ã³ããŒãçŽã«æ¬¡ã®ããã«èªã£ãŠããããç§ã¯ãã¯ããŒã«ããŽãŒã¹ãã©ã€ã¿ãŒïŒäž»èŠãªèè ã®äžäººïŒã§ãããã¬ãŽã£ã眲åè ã§ãã£ãããšã匷ãçã£ãŠããã
ã³ãããã®æ å ±å ¬éè«æ±ã¯ãADAã®ãããŒæŽ»åãžã®åœ±é¿åãæããã«ããã
ã¯ããŒã«ã®ååãçããªããã圌ã®ã¡ã¿åæãäœåºŠãåŒçšããããšã§ãã¬ãŽã£ã¯ç¬ç«ããå°éå®¶ãåŒçšããŠããããã«èŠããããšã³ãããã¯èšããããããã¬ãŽã£ãšã¯ããŒã«ã¯ãNTPã®æŽ»åã匱äœåãããããã«äœå¹ŽãååããŠããããšããè£å€è³æã§æããã«ãªã£ãŠããã
ã¬ãŽã£ã¯ãIQãšæ°Žäžã®é«æ¿åºŠã®ããåç©ãšã®éã« ãé¢é£æ§ãããå¯èœæ§ ãã瀺ã ãããããã®èšŒæ ããããã«ãããããããããåç©ã«é¢ããçŸåšã®å ¬è¡è¡çå§åã¯ããç ç©¶çµæã«åœ±é¿ãããã¹ãã§ã¯ãªã ããšçµè«ã¥ããã
ã«ããã®ããŒãããŒã«ãããµã€ã¢ã³ã»ãã¬ãŒã¶ãŒå€§åŠã®å¥åº·ç§åŠææã§ãããã«ãŒã¹ã»ã©ã³ãã£ã¢å士ãã«ãªãã©ã«ãã¢å€§åŠãµã³ãã©ã³ã·ã¹ã³æ ¡ã®å£è ç§åŠææã§ãããã¡ã©ã»ãã³ã»ãã¹ãã³å士ãããã³ãã®ãšãŒã¯å€§åŠã®èšåºå¿çåŠææã§ããã¯ãªã¹ãã£ã³ã»ãã£ã«å士ã®3人ã¯ãã¬ãŽã£ã®è§£èª¬ã«åæããªãã£ãã
ããåç©ã®æ¯æ§ã«ã€ããŠäž»èŠãªç ç©¶ãè¡ã£ãŠãã3人ã¯ãJAMAã®ã¡ã¿ã¢ããªã·ã¹ã¯çŸåšã®ããåç©æšå¥šãåè©äŸ¡ããå¿ èŠæ§ã瀺ããŠãããšè¿°ã¹ãã
ç±³åœã§ããçŽ å¡åžãå§ãŸã£ãŠä»¥æ¥ãè«æ¯ã¯æ¿æžãããšåœŒãã¯æžããŠãããããããããçŽ å ¥ãã®æ¯ç£šãç²ã®äœ¿çšãç ç³ã®æåãæžããæŠç¥-ç±³åœã¯ãã®æŠç¥ã远æ±ããŠããªã-ã«ãããããçŽ å ¥ãã®æ°Žã䜿çšããŠããªãåœã§ãåãåŸåãèµ·ãã£ãŠããã
ãã®åŸãããçŽ ã®è«æ¯äºé²å¹æã¯ã以åèããããŠãããããªæ¯ã®åœ¢æéçšã§ã®ç¡æ©åã§ã¯ãªãã屿çãªå¡åžã«ãããã®ã§ããããšãç ç©¶ã«ããæããã«ãªã£ãã
CDCãšADAã¯ãããçŽ æ·»å æ°Žã«ãã£ãŠè«æ¯ã25ïŒ æžå°ãããšããããŒã¿ã宿çã«åŒçšããŠãããããããèè ãã¯ããã®ããŒã¿ã¯ãããçŽ å ¥ãæ¯ç£šãç²ãåºãæ®åããåã«è¡ãããã質ã®äœãç ç©¶ã«åºã¥ããã®ã§ãããšè¿°ã¹ãŠãããèè ãã¯ãã³ã¯ã©ã³ã»ã¬ãã¥ãŒãæŽæ°ãããããšãææããã
圌ãèªèº«ã®ç ç©¶ã§ã¯ãLanphearãã¯ãã«ããã§ããçŽ æ·»å æ°Žã飲ãã åŠå©Šã®å°¿äžããçŽ æ¿åºŠã1.5mg/Lããé«ãããšãçºèŠããã
æ°Žéæ°ŽãããªããŒã·ã§ã³ã®æè·è ãã¡ã¯ã宿çã«æ¯ç§æ²»çãåããããšãã§ããªãäœæåŸå±€ã®åäŸãã¡ãå®ãããã«å¿ èŠã§ãããšäž»åŒµããŠããããããããã®ãããªåäŸãã¡ã¯ãéã®ãããªä»ã®ç¥çµæ¯ã«ãããããããªã¹ã¯ãé«ããããæ°ŽãããªããŒã·ã§ã³ã¯åäŸãã¡ã«ããã«å€§ããªãªã¹ã¯ãããããå¯èœæ§ãããããšåœŒãã¯æžããŠããã
NTPã®åæã«ããã°ãããåç©ã®æªåœ±é¿ã¯èªç¥æ©èœãšé¢é£ããŠããå¯èœæ§ãããããšããã圌ãã¯æ¬¡ã®ããã«çµè«ã¥ããŠããããä¿å¥æ©é¢ãèŠå¶æ©é¢ã¯ãç¹ã«åŠå©Šã乳幌å ã«å¯Ÿããããåç©ã®ãªã¹ã¯ãšãããã£ãããåè©äŸ¡ãã¹ãæã§ãããã
EPAã¯ãåäŸã®ç¥çµçºéã«åãŒããªã¹ã¯ã«åºã¥ããŠæ°Žéæ°ŽããçŽ å¡åžãèŠå¶ããæ°ããèŠåãäœãããã«ãšã®é£éŠè£å€å®ã®åœä»€ã«ç°è°ãç³ãç«ãŠãããã仿æ«ãŸã§ã«äžèšŽãæåºããªããã°ãªããªãã
ãNTPã®èª¿æ»çµæã¯ãEPAããããªããŒã·ã§ã³ããããããªã¹ã¯ããåœæ°ãå®ãããã«ãèŠå¶æªçœ®ãè¿ éã«ãšãå¿ èŠæ§ã匷調ããŠããããšã³ãããã¯è¿°ã¹ãã